Your shopping cart is currently empty

PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic obstructive pulmonary disease (COPD) [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PDE4-IN-13 is a phosphodiesterase 4 (PDE4) inhibitor exhibiting anti-inflammatory and antioxidant activities, with an half maximal inhibitory concentration (IC50) value of 1.56 μM. It is used in the research of chronic obstructive pulmonary disease (COPD) [1]. |
| Targets&IC50 | PDE4:1.56 μM |
| In vitro | PDE4-IN-13 (Compound 6o) effectively reduces the production of TNF-α induced by lipopolysaccharide (LPS) in RAW264.7 macrophages as well as malondialdehyde (MDA) generation induced by Fe2+ in mouse lung homogenates. Additionally, PDE4-IN-13 exhibits excellent capabilities in reducing Fe3+ and chelating Fe2+ [1]. |
| In vivo | PDE4-IN-13 (Compound 6o), administered intraperitoneally at doses of 50 mg/kg and 100 mg/kg, significantly prevented the elevation of serum TNF-α levels in mice induced by LPS [1]. |
| Molecular Weight | 340.37 |
| Formula | C20H20O5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.